CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord ...
SANTA CLARA, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Osteoid, previously Anatomage dental, today announced the release of Invivo One, their new 3D dental and medical imaging solution as well ...
SANTA CLARA, Calif., Jan. 2, 2025 /PRNewswire/ -- Osteoid Inc. announces that Invivo and TX Studio version 6.5 and earlier will officially reach their End of Life (EOL) on March 31, 2025. After this ...
PixarBio said today it plans to acquire InVivo Therapeutics for $77 million in stock, in a deal that would enable PixarBio CEO Frank Reynolds to combine with the company he founded in 2005. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback